Genetic modifiers in human development and malformation syndromes, including chaperone proteins.
about
Next generation sequencing technology and genomewide data analysis: Perspectives for retinal researchAutism severity is associated with child and maternal MAOA genotypesStrain background effects and genetic modifiers of hearing in mice.Identifying modifier genes of monogenic disease: strategies and difficulties.Identification of Loci Modulating the Cardiovascular and Skeletal Phenotypes of Marfan Syndrome in MiceOrganized living: from cell surfaces to basement membranes.Association of TNF-α Gene Variants With Clinical Manifestation of Cystic Fibrosis Patients of Iranian Azeri Turkish Ethnicity.HEMICENTIN-1 (FIBULIN-6) and the 1q31 AMD locus in the context of complex disease: review and perspective.In silico search for modifier genes associated with pancreatic and liver disease in Cystic FibrosisMolecular studies of phenotype variation in canine RPGR-XLPRA1.Digenic inheritance in medical geneticsDisease-modifying genes and monogenic disorders: experience in cystic fibrosis.Genetic modifiers as relevant biological variables of eye disorders.Co-chaperones are limiting in a depleted chaperone network.A delayed antioxidant response in heat-stressed cells expressing a non-DNA binding HSF1 mutant.Triallelic inheritance: a bridge between Mendelian and multifactorial traits.Modifier variant of METTL13 suppresses human GAB1-associated profound deafness.Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype.Elements of morphology: general terms for congenital anomalies.A novel HRAS substitution (c.266C>G; p.S89C) resulting in decreased downstream signaling suggests a new dimension of RAS pathway dysregulation in human development.
P2860
Q26746206-A4172A88-1F47-45EC-B327-B2A391E072EEQ28286068-0C3CD22B-E254-4DE1-9663-3AB640C39AE5Q33804884-C51748FC-AC62-4871-8393-59CD0570E526Q34025944-382657F4-842E-436D-A581-4F6A56430A7BQ34516246-33B595CD-2C25-4936-8859-825DC174CE3AQ35203220-4291FA29-AD1F-4090-837A-C2DB61F22993Q35862037-C44E7AA6-0EA6-4E74-9A11-2F2BCE072B57Q36195234-D1D9E1CE-BBF9-47EC-A298-45DC70FC169CQ36322032-B5B6E4D7-49F3-419A-8AE1-5F08D587E04CQ36794716-8E859964-5B1D-45F9-B409-13C527D41B06Q37185089-511BE768-941A-42A4-A640-8AB7E2755DF0Q38233032-4629A300-0B3C-4B0E-9F35-AE8E76CE5AD9Q39290939-1B735A2E-78E8-4358-AC85-4DB6D5CF6F76Q39691708-B65D18B3-3D23-4F64-B778-827B7178C841Q42022919-89B410E4-91B8-4F16-92E7-FC25FB58902CQ44957240-509E0503-5717-4CF1-BA78-C82F39982571Q48510407-E4064551-4F19-4C58-8924-C14078E2B3AFQ51946283-18E4A2B9-FD73-40BE-BA41-15A7BC475338Q52644315-3E9DDF96-73A7-4EF7-9D6E-CBD70D1F223BQ53155404-0CB80408-4197-4062-96FE-43B36129585B
P2860
Genetic modifiers in human development and malformation syndromes, including chaperone proteins.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Genetic modifiers in human dev ...... including chaperone proteins.
@ast
Genetic modifiers in human dev ...... including chaperone proteins.
@en
type
label
Genetic modifiers in human dev ...... including chaperone proteins.
@ast
Genetic modifiers in human dev ...... including chaperone proteins.
@en
prefLabel
Genetic modifiers in human dev ...... including chaperone proteins.
@ast
Genetic modifiers in human dev ...... including chaperone proteins.
@en
P356
P1476
Genetic modifiers in human dev ...... including chaperone proteins.
@en
P2093
Anne Slavotinek
P304
P356
10.1093/HMG/DDG099
P478
12 Spec No 1
P577
2003-04-01T00:00:00Z